1. Market Research
  2. > Manufacturing
  3. > Chemical
  4. > Petrochemical Market Trends
  5. > Bayer AG (BAYN) - Financial and Strategic SWOT Analysis Review

Bayer AG (BAYN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Bayer AG (Bayer) is a global healthcare company. It is an investment holding company for its group companies, namely, Bayer HealthCare, Bayer CropScience, Bayer MaterialScience, Bayer Business Services, Bayer Technology Services and Currenta. It focuses on the development, production and commercialization of healthcare products, nutritional supplements and specialty materials. The product portfolio of the company comprises animal health products, consumer care products, medical care products, pharmaceuticals, fungicides, insecticides, herbicides, polyurethanes, polycarbonates, coatings, adhesives and specialties. It caters to pharmaceutical, agricultural and polymer industries. The company also offers information technology (IT) and business services such as IT infrastructure and application, procurement and logistics, process development, plant engineering and construction, utility supply and waste management infrastructure services. It operates through a network of subsidiaries in Asia-Pacific, Europe, the US, and other markets such as Latin America, Africa and the Middle East. Bayer is headquartered in Leverkusen, Germany.

Bayer AG Key Recent Developments

Mar 11, 2015: Bayer aspires to significantly expand Life Science businesses
Feb 26, 2015: Bayer: strong business momentum continues and portfolio transformation underway
Feb 25, 2015: Dr. Richard Pott to be Chairman of the Supervisory Board of Bayer MaterialScience
Feb 25, 2015: Bayer proposes increased dividend for 2014 of EUR 2.25 per share
Feb 25, 2015: Bayer Thrombosis Research Award 2015 goes to Dr. Markus Bender

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table Of Contents

Bayer AG (BAYN) - Financial and Strategic SWOT Analysis Review
Table of Contents


Table of Contents 2

List of Tables
4

List of Figures
5
Section 1 - About the Company 6
Bayer AG - Key Facts 6
Bayer AG - Key Employees 7
Bayer AG - Key Employee Biographies 10
Bayer AG - Major Products and Services 11
Bayer AG - Pharmaceutical Pipeline Products Data 14
Bayer AG, Pipeline Products by Therapy Area 14
Bayer AG, Pipeline Products by Development Phase 15
Bayer AG - History 22
Bayer AG - Company Statement 35
Bayer AG - Locations And Subsidiaries 37
Head Office 37
Other Locations and Subsidiaries 37
Joint Venture 47
Section 2 - Company Analysis 48
Bayer AG - Business Description 48
Bayer AG - Corporate Strategy 50
Bayer AG - SWOT Analysis 51
SWOT Analysis - Overview 51
Bayer AG - Strengths 51
Strength - HealthCare Products 51
Strength - Strong In-house Research Expertise 51
Bayer AG - Weaknesses 52
Weakness - Product Side Effects 52
Bayer AG - Opportunities 53
Opportunity - Strategic Acquisitions 53
Opportunity - Strategic Expansion Initiatives 53
Bayer AG - Threats 54
Threat - Growing Parallel Trade 54
Threat - Government Regulations 54
Threat - Increasing Competitive Pressures 54
Bayer AG - Key Competitors 55
Section 3 - Company Financial Ratios 56
Financial Ratios - Capital Market Ratios 56
Financial Ratios - Annual Ratios 57
Performance Chart 59
Financial Performance 59
Financial Ratios - Interim Ratios 60
Financial Ratios - Ratio Charts 61
Section 4 - Company's Lifesciences, Power Financial Deals and Alliances 62
Bayer AG, Pharmaceuticals and Healthcare, Deals By Year, 2009 to YTD 2015 62
Bayer AG, Pharmaceuticals and Healthcare, Deals By Type, 2009 to YTD 2015 63
Bayer AG, Petrochemicals, Deals By Year, 2009 to YTD 2015 64
Bayer AG, Petrochemicals, Deals By Type, 2009 to YTD 2015 65
Bayer AG, Power, Deals By Year, 2009 to YTD 2015 66
Bayer AG, Power, Deals By Type, 2009 to YTD 2015 67
Bayer AG, Recent Deals Summary 68
Section 5 - Company's Recent Developments 69
Mar 11, 2015: Bayer aspires to significantly expand Life Science businesses 69
Feb 26, 2015: Bayer: strong business momentum continues and portfolio transformation underway 70
Feb 25, 2015: Dr. Richard Pott to be Chairman of the Supervisory Board of Bayer MaterialScience 73
Feb 25, 2015: Bayer proposes increased dividend for 2014 of EUR 2.25 per share 74
Feb 25, 2015: Bayer Thrombosis Research Award 2015 goes to Dr. Markus Bender 75
Feb 12, 2015: Bayer Initiates Life-Science Reorganization 77
Feb 10, 2015: Bayer launches new polycarbonate blend grade tailored for wearable medical devices 78
Jan 05, 2015: Bayer Chooses Onco360 as Limited Distribution Pharmacy Provider 79
Dec 02, 2014: Life science company Bayer steps up focus on research and development 80
Nov 17, 2014: Bayer increases its donations of medications for ebola patients to a total value of more than EUR 3.7 million 83
Section 6 - Appendix 84
Methodology 84
Ratio Definitions 84
About GlobalData 88
Contact Us 88
Disclaimer 88


List of Tables

Bayer AG, Key Facts 6
Bayer AG, Key Employees 7
Bayer AG, Key Employee Biographies 10
Bayer AG, Major Products and Services 11
Bayer AG, Number of Pipeline Products by Therapy Area 14
Bayer AG, Number of Pipeline Products by Development Stage 15
Bayer AG, Pipeline Products By Therapy Area and Development Phase 16
Bayer AG, History 22
Bayer AG, Subsidiaries 37
Bayer AG, Joint Venture 47
Bayer AG, Key Competitors 55
Bayer AG, Ratios based on current share price 56
Bayer AG, Annual Ratios 57
Bayer AG, Interim Ratios 60
Bayer AG, Pharmaceuticals and Healthcare, Deals By Year, 2009 to YTD 2015 62
Bayer AG, Pharmaceuticals and Healthcare, Deals By Type, 2009 to YTD 2015 63
Bayer AG, Petrochemicals, Deals By Year, 2009 to YTD 2015 64
Bayer AG, Petrochemicals, Deals By Type, 2009 to YTD 2015 65
Bayer AG, Power, Deals By Year, 2009 to YTD 2015 66
Bayer AG, Power, Deals By Type, 2009 to YTD 2015 67
Bayer AG, Recent Deals Summary 68
Currency Codes 84
Units 84
Capital Market Ratios 84
Equity Ratios 85
Profitability Ratios 85
Cost Ratios 86
Liquidity Ratios 86
Leverage Ratios 87
Efficiency Ratios 87


List of Figures

Bayer AG, Pipeline Products by Therapy Area 14
Bayer AG, Pipeline Products by Development Phase 15
Bayer AG, Performance Chart (2010 - 2014) 59
Bayer AG, Ratio Charts 61
Bayer AG, Pharmaceuticals and Healthcare, Deals By Year, 2009 to YTD 2015 62
Bayer AG, Pharmaceuticals and Healthcare, Deals by Type, 2009 to YTD 2015 63
Bayer AG, Petrochemicals, Deals By Year, 2009 to YTD 2015 64
Bayer AG, Petrochemicals, Deals by Type, 2009 to YTD 2015 65
Bayer AG, Power, Deals By Year, 2009 to YTD 2015 66
Bayer AG, Power, Deals by Type, 2009 to YTD 2015 67

Companies Mentioned

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers

Mexico Petrochemical Market Opportunity Analysis

Mexico Petrochemical Market Opportunity Analysis

  • $ 5 000
  • Industry report
  • April 2015
  • by Frost & Sullivan

Opportunities for the Growth of the ABS, PBT, SBR, SBS, and POE Segments Come from the Automotive and Appliance Industries The Mexican market for the resins ABS, SBR, SBS, PBT, and POE was valued at $1.06 ...

Aromatic Solvents  Market for Pharmaceuticals, Oilfield Chemicals, Automotive, Paints & Coatings, and Other End-users - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 – 2023

Aromatic Solvents Market for Pharmaceuticals, Oilfield Chemicals, Automotive, Paints & Coatings, and Other End-users - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 – 2023

  • $ 4 795
  • Industry report
  • May 2015
  • by Transparency Market Research

Solvents is a routinely used term in organic chemistry. Solvents are used to dissolve or disperse solid materials. Aromatic solvents constitute benzene, xylene, toluene, and other aromatic solvents such ...

Ethylene Market for Polyethylene, Ethylene Oxide, Ethylene Benzene, Ethylene Dichloride, and Others - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020

Ethylene Market for Polyethylene, Ethylene Oxide, Ethylene Benzene, Ethylene Dichloride, and Others - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020

  • $ 4 795
  • Industry report
  • April 2015
  • by Transparency Market Research

This report analyzes and forecasts the market for ethylene at a global and regional level. The market has been forecast based on volume (Mn Tons) and revenue (US$ Bn) from 2014 to 2020. The study includes ...


Download Unlimited Documents from Trusted Public Sources

Renewable Energy Markets in the US

  • July 2015
    127 pages
  • Renewable Energ...  

    Bio Fuel  

    Ethanol Fuel  

  • United States  

    North America  

View report >

Petrochemical Industry in Europe

  • July 2015
    5 pages
  • Petrochemical  

    Petrochemical  

  • Europe  

    BRIC  

    China  

View report >

Benzene Industry in Asia

  • July 2015
    8 pages
  • Benzene  

  • Asia  

    Europe  

    South Korea  

View report >

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.